MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Synta66

CAS No. : 835904-51-3

MCE 国际站：Synta66

产品活性：Synta66 是钙离子通道 Orai (CRAC 的核心) 的抑制剂，主要用于神经疾病的研究。

研究领域：Membrane Transporter/Ion Channel

作用靶点：CRAC Channel

In Vitro: Synta66 is an inhibitor of Orai, which forms the pore of the CRAC channel. Synta66 (10 µM) attenuates peak SOCE in Müller glia. Synta66 (10 µM) prevents orai channels mediating the residual SOC current in Trpc1^−/− Müller cells. Synta66 (10 µM) nearly completely blocks the Ca²⁺ entry signal evoked by CaCl₂ addition, whereas it moderately reduces Ca²⁺ mobilization from stores with 10% to 30% in platelet. Synta66 (10 µM) suppresses human platelet activation in plasma and whole-blood thrombus formation. Synta66 (10 µM) also inhibits murine platelet responses and thrombus formation. Synta66 (10 µM) inhibits LAD2 human mast cell line. Synta66 (10 µM) significantly inhibits FcεRI stimulated histamine and TNFα secretion, and has differential effects on FcεRI stimulated prostaglandin D2 and cytokine release in human lung mast cells (HLMCs).

相关产品：Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | SKF-96365 hydrochloride | YM-58483 | Tanshinone IIA sulfonate sodium | GSK-5498A | MRS1845 | RO2959 monohydrochloride | CRAC intermediate 2 | CRAC intermediate 1

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。